business
Sun Pharma subsidiaries settle US generic drug pricing antitrust case for confidential amount
Shares of Sun Pharmaceutical Industries Ltd ended at ₹1,842.00, down by ₹22.00, or 1.18%, on the BSE.
Read full article on Cnbctv18
Related News
